 |
JOURNAL TOOLS |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Reprints |
| Permissions |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
INTERVENTIONAL CARDIOLOGY
Minerva Cardioangiologica 2012 February;60(1):85-94
Copyright © 2012 EDIZIONI MINERVA MEDICA
language: English
Review of the MitraClip clinical evidence
Maisano F., Taramasso M., Cioni M., Buzzatti N., Denti P., Colombo A., Alfieri O. ✉
Cardiothoracic Department, San Raffaele Hospital, Milan, Italy
MitraClip system is the only catheter-based device for percutanoeus mitral valve repair available for clinical use, after receipt of the CE Mark in 2008, while it is currently under review for FDA approval in the US. To date, over 3500 MitraClip implants have been performed worldwide, mainly in high risk surgical patients. The aim of this review is to review all the current evidences of the MitraClip therapy in an aim to define its clinical role in the treatment of mitral regurgitation (MR).